A short video on CV & CKD outcomes & subgroup analysis of Credence Trial:
https://www.healio.com/endocrinology/diabetes/news/online/%7Bf2856cfc-92c4-4318-8a2e-69ba2e8090c2%7D/video-new-credence-data-demonstrates-cv-renal-benefit-in-primary-prevention-population
This is the trial Janssen were utilising PromarkerD Test for. I think Primary prevention is a big keyword here.
Have a great day all![]()
- Forums
- ASX - By Stock
- Ann: PromarkerD to feature at world's largest diabetes conference
PIQ
proteomics international laboratories ltd
Add to My Watchlist
0.00%
!
30.5¢

A short video on CV & CKD outcomes & subgroup analysis of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.87M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.310 |
1 | 3253 | 0.305 |
2 | 3363 | 0.300 |
1 | 10172 | 0.295 |
1 | 150000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 7000 | 1 |
0.300 | 12700 | 2 |
0.305 | 24764 | 2 |
0.325 | 9000 | 2 |
0.330 | 57411 | 2 |
Last trade - 09.28am 26/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online